deltatrials

Stage iii rectal cancer ajcc v8 Trials in Houston, United States

Conditions / Stage iii rectal cancer ajcc v8 / Houston, United States

Stage iii rectal cancer ajcc v8 has been the subject of sustained clinical investigation across multiple research sites.

10 total trials for this combination

Trials

NCT ID Title Status Phase
NCT02874885 Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer ACTIVE_NOT_RECRUITING
NCT03765736 Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial TERMINATED
NCT05610163 Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation ACTIVE_NOT_RECRUITING PHASE2
NCT04929028 Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer RECRUITING PHASE2
NCT05308446 Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation ACTIVE_NOT_RECRUITING
NCT03992456 Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer ACTIVE_NOT_RECRUITING PHASE2
NCT04616183 LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer ACTIVE_NOT_RECRUITING PHASE1/PHASE2
NCT02107105 Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer SUSPENDED
NCT03594630 Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer RECRUITING EARLY_PHASE1
NCT04599140 SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial ACTIVE_NOT_RECRUITING PHASE1/PHASE2

Related Pages